South Shore Biotherapy

South Shore Biotherapy

Closed: Apr. 2022

About this raise

South Shore Biotherapy is raising funds on MainVest. It is a mental health office that helps to improve the quality of life of its clients through intravenous infusion therapy. The therapy provides patients with hope for a better future, free of depression and suicidal thoughts. South Shore Biotherapy aims to become the unmatched provider of ketamine infusion therapy in the Marshfield area. Adam Joseph Baiardi founded South Shore Biotherapy in July 2021. The current crowdfunding campaign has a minimum target of $75,000 and a maximum target of $107,000. The campaign proceeds will be used for buildout, facility lease, medical equipment, staff salary, and furnishings.

Expand

Investment Overview

Invested this round: $105,000

Deal Terms

Total Commitments

Platform
MainVest
Start Date
08/30/2021
Close Date
04/15/2022
Min. Goal
$75,000
Max Goal
$107,000
Min. Investment

$100

Security Type

Revenue Share

SEC Filing Type

RegCF    Open SEC Filing

Company & Team

Company

Year Founded
2021
Industry
Fitness & Wellness
Tech Sector
Non-Tech
Distribution Model
B2C
Margin
Low
Capital Intensity
Low
Location
Marshfield, Massachusetts
Business Type
Life Style
Company Website
Visit Website

Team

Employees
1
Prior Founder Exits?
No
Founder Name
Adam Baiardi
Title
CEO

Financials

 Revenue
$0
 Cash on Hand
$0

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/15/2022 MainVest - $105,000 Revenue Share Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
South Shore Biotherapy on MainVest 2021
Platform: MainVest
Security Type: Revenue Share

Follow company

Follow South Shore Biotherapy on MainVest 2021

Buy South Shore Biotherapy's Deal Report

Warning: according to the close date for this deal, South Shore Biotherapy may no longer be accepting investments.

South Shore Biotherapy Deal Report

Get Kingscrowd's comprehensive report on South Shore Biotherapy including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether South Shore Biotherapy is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the South Shore Biotherapy deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge